<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04350879</url>
  </required_header>
  <id_info>
    <org_study_id>PO20041</org_study_id>
    <nct_id>NCT04350879</nct_id>
  </id_info>
  <brief_title>Diabetes Mellitus and Pregnancy : Knowledge Assessment</brief_title>
  <acronym>DMPKA</acronym>
  <official_title>Evaluation of Knowledge About Contraception and Pregnancy Planning Among Type 1 and Type 2 Diabetes Women</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>CHU de Reims</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>CHU de Reims</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Diabetes, a chronic and frequent disease, is a risk factor of pregnancy complications such as
      preeclampsia, congenital malformations and macrosomia.

      Preconception care is all methods to assess the best prognostic for a diabetic pregnancy.
      Among these methods, contraception is very important to plan the pregnancy on a chosen
      moment.

      The content of the preconception care is well established. However, information of diabetic
      women concerning contraception and giabetic pregnancy has been little studied.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of the study is to describe the knowledge of the patients with diabetes concerning
      contraception and pregnancy planning.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 17, 2020</start_date>
  <completion_date type="Anticipated">October 17, 2020</completion_date>
  <primary_completion_date type="Anticipated">August 17, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Risk of unplanned pregnancy</measure>
    <time_frame>Day 0</time_frame>
    <description>Knowledge concerning the risk of unplanned pregnancy in diabete women</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>Diabetic patients</arm_group_label>
    <description>Women between 18 and 40 years old with type 1 and type 2 diabetes</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Data record</intervention_name>
    <description>Data record</description>
    <arm_group_label>Diabetic patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Women between 18 and 40 years old, consulting in diabetology department of Reims
        Universitary Hospital and Charleville Mézières General Hospital
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        inclusion criteria :

          -  Patients Aged between 18 and 40 years old

          -  With type 1 or type 2 diabetes mellitus

          -  Consulting in the department of diabetology in Reims and Charleville Mezieres
             hospitals

          -  Accepting to participate in the study

        exclusion criteria :

          -  Patients With secondary diabetes (endocrine, pancreatic or genetical origin)

          -  With postmenopausal status

          -  Without capacity to have a pregnancy (uterine aplasia, hysterectomy)
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Aurélie DUPONT MARQUET</last_name>
    <phone>0626427096</phone>
    <phone_ext>0033</phone_ext>
    <email>adupont@chu-reims.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Damien JOLLY</name>
      <address>
        <city>Reims</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aurélie DUPONT MARQUET</last_name>
      <phone>0626427096</phone>
      <phone_ext>0033</phone_ext>
      <email>adupont@chu-reims.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>April 15, 2020</study_first_submitted>
  <study_first_submitted_qc>April 16, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 17, 2020</study_first_posted>
  <last_update_submitted>April 16, 2020</last_update_submitted>
  <last_update_submitted_qc>April 16, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Diabetes mellitus</keyword>
  <keyword>pregnancy</keyword>
  <keyword>contraception</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

